B-cell non-Hodgkin’s Lymphoma

December 12, 2018

Follow-up Trial Results Reinforce Yescarta as Relapsed Non-Hodgkin’s Lymphoma Therapy

News

More than two years after receiving treatment with Yescarta (axicabtagene ciloleucel), 51% of non-Hodgkin’s lymphoma patients included in the ZUMA-1 Phase 1/2 clinical trial are still alive, and 39% are ... Read more

October 17, 2018

AFM11 Clinical Program for Lymphoma and Leukemia on Hold Over Safety Concerns

News

Affimed has placed its AFM11 Phase 1 program on clinical hold after two life-threatening events in its lymphoma trial and one death in the leukemia study, the company announced in a press release. ... Read more

August 3, 2018

Gazyva Infusion Could Be Shorter for Some NHL Patients, Study Finds

News

Shortening the time needed for an infusion of Gazyva (obinutuzumab) did not affect the safety of Japanese patients with previously untreated CD20-positive B-cell non-Hodgkin’s lymphoma, a new study shows. “Safety, tolerability ... Read more

April 15, 2016April 15, 2016

Antiviral Therapy Works as a Lymphoma Treatment in Patients with Hepatitis C, Study Reports

News

Antiviral therapy efficiently contributes to cancer treatment response in patients with hepatitis C virus infection and B-cell non-Hodgkin’s lymphoma, an analysis of previously published data revealed. The findings may change the ... Read more